Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of SUSMED,Inc.. A complete text table follows the diagram.
The platform business generated JPY91 million, while JPY377 million of disclosed costs supported clinical products and infrastructure.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Selling General And Administrative Expenses | 1 | 255M | 67.6% of reported total |
| Research And Development Expenses SGA | 1 | 113M | 29.9% of reported total |
| Cost of business revenue | 1 | 9.2M | 2.4% of reported total |
| Other & rounding | 1 | 0 | 0.0% of reported total |
| Total business expenses | 2 | 377M | Reported six-month total · ¥377M |
| Operating loss | 2 | 286M | Absolute value of reported operating loss |
| Operating costs & expenses | 3 | 664M | Revenue plus reported operating loss |
| From | To | Value |
|---|---|---|
| Selling General And Administrative Expenses | Total business expenses | 255M |
| Research And Development Expenses SGA | Total business expenses | 113M |
| Cost of business revenue | Total business expenses | 9.2M |
| Other & rounding | Total business expenses | 0 |
| Total business expenses | Operating costs & expenses | 377M |
| Operating loss | Operating costs & expenses | 286M |